Nachrichten zur AstraZeneca PLC Aktie

Sanofi to get commercial control of RSV therapy nirsevimab in US, AstraZeneca to record $0.7B gain

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi bekommt Astrazeneca-Anteil an RSV-Lizenz in USA

Von Cecilia Butini BARCELONA (Dow Jones)--Sanofi bekommt die volle kommerzielle Kontrolle über eine Antikörperbehandlung gegen das Respiratorische Synzytialvirus (RSV)…

AstraZeneca releases US$0.7bn after simplifying US RSV deal

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi Gets Full Commercial Control on Virus Medication From AstraZeneca in U.S.

Sanofi Gets Full Commercial Control on Virus Medication From AstraZeneca in U.S....…

Update to arrangements with Sobi and Sanofi

11 April 2023 07:00 BST Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi AstraZeneca, Swedish Orphan Biovitrum AB…

Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements

Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know

Astrazeneca (AZN) closed at $72.07 in the latest trading session, marking a -0.37% move from the prior day....…

The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer

J&J, AstraZeneca, Merck, Seagen and Pfizer are part of the Zacks Top Analyst Blog....…

Sobi to streamline nirsevimab contractual arrangements

Nirsevimab economics simplified through a new royalty agreement with Sanofi and the termination of the participation agreement with AstraZeneca Alignment will…

AstraZeneca premium justified by long-term potential says broker

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights Mastercard, AstraZeneca, Philip Morris, TJX and Citigroup

Mastercard, AstraZeneca, Philip Morris, TJX and Citigroup are included in this Analyst Blog....…

GSK ordered by UK court to pay more royalties to AstraZeneca on Zejula sales - report

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Mastercard, AstraZeneca & Philip Morris

Todays Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AstraZeneca PLC (AZN) and Philip…

Futures Dip Ahead Of Private Payrolls Data, After Hawkish Surprise Out Of New Zealand

Futures Dip Ahead Of Private Payrolls Data, After Hawkish Surprise Out Of New Zealand …

UK court orders GSK to pay AstraZeneca royalties on total sales of Zejula

...(Reuters) - A UK court on Wednesday ordered GSKs Tesaro to pay......…

Form 6-K ASTRAZENECA PLC For: Apr 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Imfinzi, Lynparza combo improves progression-free survival in ovarian cancer trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca drug combo improves ovarian cancer survival rate

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca: Lynparza Combination Improves PFS In Phase III Ovarian Cancer Trial

LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN, AZN.L) said results from an interim analysis of the DUO-O Phase…

RPT-UPDATE 1-AstraZeneca says drug combo meets goal in late-stage ovarian cancer trial

... (Reuters) - AstraZeneca on Wednesday said a combination of its cancer......…

UPDATE 1-AstraZeneca says drug combo meets goal in late-stage ovarian cancer trial

...(Adds detail on analysis, background on Lynparza) April 5 (Reuters......…

AstraZeneca says cancer drug combination meets late-stage trial goal

...April 5 (Reuters) - AstraZeneca said on Wednesday a combination......…

Drug giant AstraZeneca teams up with Hong Kong Science Park to drive biotech, medical research growth

The latest collaboration will involve AstraZeneca and HKSTP providing services to overseas and mainland Chinese start-ups under the park’s incubation…

Astrazeneca (AZN) Gains As Market Dips: What You Should Know

Astrazeneca (AZN) closed the most recent trading day at $70.25, moving +0.49% from the previous trading session....…

Form 6-K ASTRAZENECA PLC For: Apr 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca (AZN) Ultomiris Gets CHMP Nod for New Rare Disease

CHMP recommends AstraZenecas (AZN) Ultomiris for the treatment of patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive....…

Total Voting Rights

3 April 2023 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca: CHMP Recommendes Ultomiris For EU Approval For Neuromyelitis Optica Spectrum Disorde

LONDON (dpa-AFX) - British drug major AstraZeneca PLC (AZN, AZN.L) announced Monday that the Committee for Medicinal Products for Human…

AstraZeneca Ultomiris gets EMA backing for expanded use

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K ASTRAZENECA PLC For: Mar 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Risk Of Cardiac Death Tripled For Young Women Following AstraZeneca COVID-19 Vaccination: Study

Risk Of Cardiac Death Tripled For Young Women Following AstraZeneca COVID-19 Vaccination: Study …

AstraZeneca signs exclusive global license deal with KYM Biosciences

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Completes KYM Solid Tumors Treatment Deal

AstraZeneca Completes KYM Solid Tumors Treatment Deal...…

AstraZeneca completes KYM agreement for CMG901

30 March 2023 07:00 BST License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed AstraZeneca has completed an…

Astrazeneca (AZN) Gains But Lags Market: What You Should Know

In the latest trading session, Astrazeneca (AZN) closed at $68.64, marking a +0.06% move from the previous day....…

AstraZeneca Axes Pneumonia Drug Pact With Aridis

AstraZeneca plc (NASDAQ: AZN) scrapped its license agreement with Aridis Pharmaceuticals Inc (NASDAQ: ARDS). read more...…

Salipro Biotech publishes research in Scientific Reports on structure-function studies for membrane proteins in collaboration with AstraZeneca

Stockholm, March 28, 2023 – Salipro Biotech today announces the publication of results from a collaboration with AstraZeneca. The study…

dpa-AFX ProFeed